Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Archive of News

<< 2010 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2012 >>

31 August 2011: Entrepreneur and co-founder of YouGov PLC, Stephan Shakespeare, writing in CityAM this morning, has announced the winners of StartUp Summer 2011

STEPHAN SHAKESPEARE
Back in July, I wrote about the launch of StartUp Summer, a scheme to encourage innovation and entrepreneurship among students organised by YouGov with University College London and Imperial College, and supported by Downing Street.
More...

23 August 2011: UCLB supports the UCL Ear Institutes’ work with GSK spinout company Autifony

The UCL Ear Institute, with support from UCLB, is delighted to be working with Autifony Therapeutics Limited (Autifony) to develop effective treatments for tinnitus and other hearing disorders.
More...

9 August 2011: UCLB spinout company, Endomagnetics Ltd Secures Funding for Expansion and Product Launch

UCLB spinout company Endomagnetics Ltd, whose magnetic sensing technology will extend the availability of best practice in cancer staging on a global basis, closed a £1.2 million investment round on 5th August 2011. More...

<< 2010 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2012 >>